Gene · 4593
Papers3,141
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
221 to 240 of 3,141
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| ARGX-119 is an agonist antibody for human MuSK that reverses disease relapse in a mouse model of congenital myasthenic syndrome. | Sci Transl Med | 2024 | 39292800 | PubTator, text mining | PubMed |
| Agonist antibody to MuSK protects mice from MuSK myasthenia gravis. | Proc Natl Acad Sci U S A | 2024 | 39288173 | PubTator, text mining | PubMed |
| Serological Markers of Clinical Improvement in MuSK Myasthenia Gravis. | Neurol Neuroimmunol Neuroinflamm | 2024 | 39250722 | PubTator, text mining | PubMed |
| An Inflammatory Myofibroblastic Tumour Presenting with Limited Mouth-Opening, Hypoesthaesia of The Left Chin and Infraorbital Area, Intermittent Left Eye Ptosis and Converging Strabismus. | Eur J Case Rep Intern Med | 2024 | 39247249 | PubTator, text mining | PubMed |
| A patient treated with ofatumumab for myasthenia gravis in conjunction with systemic lupus erythematosus and thyroid carcinoma. | Intractable Rare Dis Res | 2024 | 39220275 | PubTator, text mining | PubMed |
| Characterizing Myasthenia Gravis Symptoms, Exacerbations, and Crises From Neurologist's Clinical Notes Using Natural Language Processing. | Cureus | 2024 | 39219871 | PubTator, text mining | PubMed |
| Myasthenia gravis. | Handb Clin Neurol | 2024 | 39174248 | PubTator, text mining | PubMed |
| Efgartigimod as a promising add-on therapy for myasthenic crisis: a prospective case series. | Front Immunol | 2024 | 39136012 | PubTator, text mining | PubMed |
| Myasthenia gravis: the future is here. | J Clin Invest | 2024 | 39105625 | PubTator, text mining | PubMed |
| Clinical and laboratory remission with rituximab in anti-MuSK-positive myasthenia gravis. | Ir J Med Sci | 2024 | 39088160 | PubTator, text mining | PubMed |
| A real-life experience with eculizumab and efgartigimod in generalized myasthenia gravis patients. | J Neurol | 2024 | 39080054 | PubTator, text mining | PubMed |
| Myasthenia gravis Lambert-Eaton overlap syndrome: Recommended modification for the diagnostic criteria. | Muscle Nerve | 2024 | 39072842 | PubTator, text mining | PubMed |
| A class of chemical compounds enhances clustering of muscle nicotinic acetylcholine receptor in cultured myogenic cells. | Biochem Biophys Res Commun | 2024 | 39024975 | PubTator, text mining | PubMed |
| Scaffold-Forming Collagen and Motor-Endplate Expressing Muscle Cells for Porcine Laryngoplasty. | Laryngoscope | 2024 | 39011835 | PubTator, text mining | PubMed |
| Cancer Frequency in MuSK Myasthenia Gravis and Histological Evidence of Paraneoplastic Etiology. | Ann Neurol | 2024 | 39007444 | PubTator, text mining | PubMed |
| An unusual initiation of an ocular form of MuSK-positive myasthenia gravis after magnesium administration: a rare case report. | Ann Med Surg (Lond) | 2024 | 38989207 | PubTator, text mining | PubMed |
| A Case Report of MuSK Antibody-Positive Myasthenia Gravis. | Cureus | 2024 | 38975540 | PubTator, text mining | PubMed |
| Efgartigimod for generalized myasthenia gravis: A multicenter real-world cohort study in China. | Ann Clin Transl Neurol | 2024 | 38973109 | PubTator, text mining | PubMed |
| Therapeutic challenges and unmet needs in the management of myasthenia gravis: an Italian expert opinion. | Neurol Sci | 2024 | 38967883 | PubTator, text mining | PubMed |
| Congenital Myasthenic Syndromes in Belgium: Genetic and Clinical Characterization of Pediatric and Adult Patients. | Pediatr Neurol | 2024 | 38964204 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/4593/papers?page=12